Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
32-<31
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
59-<64
General Information
Revision date
2022-10-12
Product name
RELANIUM TABLETS
Product Synonyms
RELANIUM TABLETS 2 MG * RELANIUM TABLETS 5 MG * DIAZEPAM, FORMULATED
1.2.2. Uses advised against
No other uses are advised
supplier name
GSK US
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GSK US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Acute toxicity, dermal Category 3
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 3
Signal word
Danger
Hazard statements
Harmful if swallowed. Toxic in contact with skin. Toxic if inhaled. Harmful to aquatic life. Harmful to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Avoid breathing dust. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves/protective clothing.
Response
IF SWALLOWED: Call a POISON CENTRE/doctor// if you feel unwell. Rinse mouth. Call a POISON CENTRE/doctor/. Specific treatment (see instruction on this label). Take off immediately all contaminated clothing and wash it before reuse.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
31.77 % of the mixture consists of component(s) of unknown acute oral toxicity. 90.83 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99.43 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 90.83 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 90.83 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
